67
Participants
Start Date
July 31, 2002
Study Completion Date
August 31, 2004
Climodien / Lafamme (BAY86-5027)
1 tablet daily (2 mg EV + 2 mg DNG)
Placebo
1 tablet daily
Vienna
Lead Sponsor
Bayer
INDUSTRY